1.035
price up icon0.98%   0.01
after-market After Hours: 1.04 0.005 +0.48%
loading
Achilles Therapeutics Plc Adr stock is traded at $1.035, with a volume of 106.83K. It is up +0.98% in the last 24 hours and up +0.86% over the past month. Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
See More
Previous Close:
$1.025
Open:
$1.01
24h Volume:
106.83K
Relative Volume:
0.17
Market Cap:
$41.91M
Revenue:
-
Net Income/Loss:
$-63.97M
P/E Ratio:
-0.575
EPS:
-1.8
Net Cash Flow:
$-62.91M
1W Performance:
+4.01%
1M Performance:
+0.86%
6M Performance:
+28.78%
1Y Performance:
+19.89%
1-Day Range:
Value
$1.00
$1.05
1-Week Range:
Value
$0.9753
$1.05
52-Week Range:
Value
$0.63
$1.76

Achilles Therapeutics Plc Adr Stock (ACHL) Company Profile

Name
Name
Achilles Therapeutics Plc Adr
Name
Phone
-
Name
Address
-
Name
Employee
215
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
ACHL's Discussions on Twitter

Achilles Therapeutics Plc Adr Stock (ACHL) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-26-21 Initiated BofA Securities Buy
Apr-26-21 Initiated Chardan Capital Markets Buy
Apr-26-21 Initiated JP Morgan Underweight
Apr-26-21 Initiated Oppenheimer Outperform
Apr-26-21 Initiated Piper Sandler Overweight

Achilles Therapeutics Plc Adr Stock (ACHL) Latest News

pulisher
Sep 23, 2024

ACHL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Check Out Achilles Therapeutics Plc ADR (ACHL)’s Trade Data Rather Than the Analysts’ Views - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Sep 23, 2024
pulisher
Sep 20, 2024

why Achilles Therapeutics Plc ADR [ACHL] is a Good Choice for Investors After New Price Target of $1.25 - The DBT News

Sep 20, 2024
pulisher
Sep 20, 2024

What Analysts Were Expecting After PowerFleet Inc (NASDAQ: AIOT) rose 2.40% - Stocks Register

Sep 20, 2024
pulisher
Sep 20, 2024

Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter

Sep 20, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics ends TIL-based cancer therapy trials - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

You Should Read This Analysis Before Investing in Achilles Therapeutics Plc ADR (NASDAQ:ACHL) - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles stock climbs on strategic focus (NASDAQ:ACHL) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics Announces Strategic Update - Yahoo Finance

Sep 19, 2024
pulisher
Aug 14, 2024

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - GlobeNewswire

Aug 14, 2024
pulisher
Aug 14, 2024

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - GlobeNewswire Inc.

Aug 14, 2024
pulisher
Jun 27, 2024

Immunovant (IMVT) Up More Than 20% in Past 3 Months: Here's Why - Yahoo New Zealand News

Jun 27, 2024
pulisher
Jun 24, 2024

Kodiak Sciences (KOD) Rises 60% in Past 3 Months: Here's Why - Yahoo Sport Australia

Jun 24, 2024
pulisher
Jun 19, 2024

Achilles Therapeutics Plc ADR (ACHL) Clearly Signals Buy-Into the Stock: Don't ignore the signals – Sete News - SETE News

Jun 19, 2024
pulisher
Jun 04, 2024

Amgen's (AMGN) Lumakras Meets Goal in New Lung Cancer Study - Yahoo Lifestyle UK

Jun 04, 2024
pulisher
May 25, 2024

Blueprint Medicines' (BPMC) Ayvakit Meets Goal in PIONEER Study - Yahoo Movies UK

May 25, 2024
pulisher
May 24, 2024

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development - Yahoo Lifestyle UK

May 24, 2024
pulisher
May 22, 2024

Achilles Therapeutics and Arcturus team up for cancer vaccine By Investing.com - Investing.com

May 22, 2024
pulisher
May 22, 2024

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation ... - GlobeNewswire

May 22, 2024
pulisher
May 22, 2024

Achilles Therapeutics Announces Research Collaboration with - GlobeNewswire

May 22, 2024
pulisher
May 17, 2024

Achilles Therapeutics faces Nasdaq delisting over share price - Investing.com

May 17, 2024
pulisher
May 17, 2024

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewswire

May 17, 2024
pulisher
May 12, 2024

Horizon (HZNP) Inks Collaboration Deal with Q32 Bio for ADX-914 - Yahoo New Zealand News

May 12, 2024
pulisher
May 10, 2024

AstraZeneca (AZN) Gets Japan Nod for Expanded Use of 3 Drugs - Yahoo Movies UK

May 10, 2024
pulisher
May 10, 2024

Amgen (AMGN) Posts Positive Data from Soliris' Biosimilar Study - Yahoo News UK

May 10, 2024
pulisher
May 09, 2024

Achilles Therapeutics Plc ADR's Shares Reel: -0.12% Quarterly Revenue Decline Amid 37.75M Market Cap – Invest ... - The InvestChronicle

May 09, 2024
pulisher
May 08, 2024

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

May 08, 2024
pulisher
Apr 04, 2024

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC ... - GlobeNewswire

Apr 04, 2024
pulisher
Feb 09, 2024

Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Feb 09, 2024
pulisher
Feb 05, 2024

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference - GlobeNewswire

Feb 05, 2024
pulisher
Jan 24, 2024

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 24, 2024
pulisher
Nov 13, 2023

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights - GlobeNewswire

Nov 13, 2023
pulisher
Sep 20, 2023

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation - Quantisnow

Sep 20, 2023
pulisher
Nov 01, 2022

What Makes Achilles Therapeutics PLC Sponsored ADR (ACHL) a New Buy Stock - Yahoo Finance

Nov 01, 2022
pulisher
Sep 09, 2022

Apellis (APLS) Up More Than 60% in Past 3 Months: Here's Why - Nasdaq

Sep 09, 2022
pulisher
Sep 05, 2022

Immuneering (IMRX) Files IND for Cancer Candidate IMM-1-104 - Yahoo Finance

Sep 05, 2022
pulisher
Aug 22, 2022

Axsome (AXSM) Soars on FDA Nod for Depression Drug, Auvelity - Yahoo Finance Australia

Aug 22, 2022
pulisher
Jun 30, 2022

Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board - GlobeNewswire

Jun 30, 2022
pulisher
Dec 24, 2021

Achilles Therapeutics PlcADR Shares Close the Day 10.1% HigherDaily Wrap - Nasdaq

Dec 24, 2021
pulisher
Mar 30, 2021

Achilles Therapeutics Announces Pricing of Initial Public Offering - GlobeNewswire

Mar 30, 2021
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011

Achilles Therapeutics Plc Adr Stock (ACHL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):